摘要
目的用基因芯片检测的方法检测抗高血压药物的相关基因,指导抗高血压药物的个性化给药方式,提高用药有效率,减少不良反应的发生。方法原发性高血压患者20例,高血压病史3~20a,服用药物为:血管紧张肽Ⅱ受体(AT1)拮抗药类(如洛沙坦、依贝沙坦、缬沙坦等);β受体阻断药(如美托洛尔、阿替洛尔等);血管紧张肽转换酶抑制药(ACEI,如依那普利、贝那普利等)。抽取患者血液2mL,用基因芯片对与抗高血压药物相关的5个位点进行检测。野生型纯合子判读为“WW”,杂合子判读为“WM”,突变型纯合子判读为“MM”。结果5个抗高血压药物相关基因检测位点的“WW”“WM”“MM”所占比例分别为:CYP2C9位点(85%,15%,0%),B受体位点(15%,40%,45%),AT1位点(80%,20%,0%),CYP2136位点(25%,20%,55%),ACEI位点(40%,40%,20%)。结论CYP2C9及AT1位点基因型分析用于给出AT1受体阻断药;CYP2D6及β受体位点基因型用于给出β受体阻断药;ACEI位点用于给出ACEI类药物的个体化给药方案和预测不良反应的发生风险。该方法用于临床原发性高血压患者的基因型检测,能够大大提高药物使用的有效率,并有效降低不良反应发生率,值得临床推广使用。
Objective To study the gene polymorphisms of hypertension drug's related gene in hypertension patients. Methods Twenty patients with hypertension history from 3 to 20 years, who were treated by AT1 -receptor antagonism (for instance : losartan, irbesartan, valsartan) , β-receptor block (for instance : metoprolol, atenoIol ) , ACE inhibitors ( for instance : enalapril, benazepril)were collected. DNA was extracted form 2 mL peripheralblood. 5 hypertensionrelated gene sites were detected by gene chip. Results In 20 hypertensive patients, rates of wide genotype, heterozygote and mutated genotype in CYP2C9 gene site were 85% ,15%and 0% ,respectively; in β-receptor block site were 15% ,40% and 45% ; in AT1-receptor site were 80% ,20% and 0% ;in CYP2D6 site were 25% ,20% and 55% ;and in hierarchize ACEI site were 40% ,40% and 20%, respectively. Conclusion The gene type detection based on gene chip might classify hypertensive patients to provide more effective therapy and lower ADR.
出处
《医药导报》
CAS
2008年第12期1518-1521,共4页
Herald of Medicine